GMCSF treatment associated with improved cognition in cancer patients, USF-Moffitt study finds

Thursday, June 21, 2012

Growth factors shown to cure Alzheimer’s disease in a mouse model and administered to cancer patients as part of their treatment regimen were linked to significant improvements in the patients’ cognitive function following stem cell transplantation, a preliminary clinical study reports.